5.26
price down icon1.13%   -0.06
after-market Handel nachbörslich: 5.30 0.04 +0.76%
loading

Finanzdaten der Protara Therapeutics Inc-Aktie (TARA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
29.26%
19.08
14.76 16.59 14.12 14.31
Operating Income/Loss
29.26%
-19.08
-14.76 -16.59 -14.12 -14.31
Nonoperating Income/Loss
17.98%
1.772
1.502 1.626 2.21 1.543
Income/Loss From Continuing Operations Before Tax
835.28%
97.48
-13.26 -14.96 -11.91 -32.54
Income/Loss From Continuing Operations After Tax
918.55%
108.52
-13.26 -14.96 -11.91 -12.77
Net Income/Loss
30.54%
-17.31
-13.26 -14.96 -11.91 -12.77
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
97.44%
1.0801
42.27 42.27 40.71 2.2503
Diluted Average Shares
97.44%
1.0801
42.27 42.27 40.71 2.2503
Basic Earnings Per Share
22.58%
-0.38
-0.31 -0.35 -0.29 -0.43
Diluted Earnings Per Share
22.58%
-0.38
-0.31 -0.35 -0.29 -0.43
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):